Timothy James Rink

Timothy James Rink

Director/Board Member at
Kymab Ltd.
80 year
Health Technology
Electronic Technology
Commercial Services

Profile

Timothy James Rink is a former Chairman, President & CEO of Aurora Biosciences Corp.
He was also the Chairman-Technology Transfer Division of The Wellcome Trust Ltd. He is currently a Non-Executive Director at Kymab Ltd. and a Director at Kymab Group Ltd. In addition, he has held various director positions at several companies including Sumitomo Pharma America, Inc., NPS Pharmaceuticals, Inc., Alanex Corp., Akubio Ltd., Lorantis Ltd., Astex Therapeutics Ltd., Gryphon Therapeutics, Inc., BioVex Ltd., Adnexus, Solexa Ltd., Ciphergen Biosystems KK, Santhera Pharmaceuticals Holding AG, and Stevenage Bioscience Catalyst.
Rink has also served as a Member-Scientific Advisory Board at Serono SA. Rink holds a graduate and doctorate degree from the University of Cambridge.

Timothy James Rink active positions

CompaniesPositionStart
Director/Board Member -
Director/Board Member 22/11/2016

Former positions of Timothy James Rink

CompaniesPositionEnd
Chairman 17/07/2022
SANTHERA PHARMACEUTICALS HOLDING AG Director/Board Member -
Corporate Officer/Principal 31/12/2009
Director/Board Member 19/10/2009
Director/Board Member 30/09/2005
See the detail of Timothy James Rink's experience

Training of Timothy James Rink

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

73

1st degree connections

23

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies23

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Miscellaneous

Health Technology

Electronic Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Electronic Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Timothy James Rink